Back

The clinical and biochemical effects of atrial fibrillation on heart failure with reduced ejection fraction; a sub-saharan African perspective

29 August 2022 (13:15 - 13:45)
Organised by:
Congress Presentation Part of: Interplay between heart failure and atrial fibrillation Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Nene Mboweni

University of the Witwatersrand, Johannesburg (South Africa)

4 More presentations in this session

Presentation thumbnail
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk score
Doctor K. Ishii (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Echocardiographic parameters of left atrial structure and function in elderly patients with atrial fibrillation, and clinical outcomes at 2 years: The ANAFIE echocardiographic substudy
Doctor S. Ikeda (Fukuoka, JP)
Abstract Slides
Presentation thumbnail
The association of left ventricular ejection fraction with incident heart failure in patients with atrial fibrillation
Doctor Y. Hamatani (Boston, US) Doctor N. Masunaga (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Catheter ablation of persistent atrial fibrillation with heart failure improves hemodynamic status without deteriorating renal function in the elderly.
Doctor A. Okahara (Fukuoka, JP)
Abstract Slides

Access the full session

Session thumbnail
Interplay between heart failure and atrial fibrillation

The Event

Event poster

ESC Congress 2022

29 August 2022 13:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources